Loading clinical trials...
Loading clinical trials...
The purpose of this study is to demonstrate the effectiveness of RSD1235 compared with placebo, in the conversion of atrial fibrillation or atrial flutter to sinus rhythm.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Astellas Pharma Inc
Collaborators
NCT05009797 · Atrial Fibrillation
NCT07421076 · Paroxysmal Atrial Fibrillation (PAF)
NCT06500988 · Atrial Fibrillation, Behavior
NCT07490808 · Atrial Fibrillation (AF), Acute Kidney Injury
NCT07429214 · Atrial Fibrillation
Investigative Site
Birmingham, Alabama
Investigative Site
Huntsville, Alabama
Investigative Site
Gainesville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions